An Observational Study to Validate the Cumulative Life Course Impairment (CLCI) Instrument (DermCLCI-p) in Adult Participants With Moderate to Severe Chronic Plaque Psoriasis (PsO)

NCT05959070 · clinicaltrials.gov ↗
COMPLETED
Status
154
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

AbbVie